ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
124.124,37
-0,39%
S&P 500
6.083,93
0,54%
US Dollar vs BRL
6,0981
0,92%
Bitcoin
106.506,89
2,08%
Brent Oil
73,58
-0,80%
As Melhores Corretoras Online
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. AMEX
  6. OS Therapies Incorporated (OSTX)

  7. OS Therapies Incorporated (OSTX) Notícias

OSTX

OS Therapies (OSTX)

OS Therapies Incorporated
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:AMEX:OSTX
DataHoraFonteTítuloCódigoCompanhia
15/11/202418:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:OSTXOS Therapies Incorporated
15/11/202411:47Business WireOS Therapies Reports Third Quarter 2024 Financial Results and Provides Business UpdateAMEX:OSTXOS Therapies Incorporated
15/11/202411:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:OSTXOS Therapies Incorporated
14/11/202418:58Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBAMEX:OSTXOS Therapies Incorporated
04/11/202409:00Business WireOS Therapies to Present at The Spartan Capital Investor ConferenceAMEX:OSTXOS Therapies Incorporated
30/10/202409:51Business WireJoin OS Therapies’ Exclusive Live Investor Webinar and Q&A Session on October 30AMEX:OSTXOS Therapies Incorporated
29/10/202417:10Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:OSTXOS Therapies Incorporated
28/10/202417:44Business WireOS Therapies Appoints Two Bio-Pharmaceutical Industry Veterans to the Board of DirectorsAMEX:OSTXOS Therapies Incorporated
24/10/202409:46Business WireOS Therapies to Present at the LD Micro Main Event XVIIAMEX:OSTXOS Therapies Incorporated
17/10/202410:22Business WireOS Therapies to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual SummitAMEX:OSTXOS Therapies Incorporated
03/10/202409:00Business WireOS Therapies Announces Last Patient Enrolled in OST-HER2 Osteosarcoma Phase 2b Clinical Trial Completes Last Patient VisitAMEX:OSTXOS Therapies Incorporated
13/09/202409:09Business WireOS Therapies Announces Development of Two Novel Tunable Antibody Drug Conjugate (tADC)-Based Therapeutic CandidatesAMEX:OSTXOS Therapies Incorporated
05/09/202409:22Business WireOS Therapies to Present at H.C. Wainright 26th Annual Global Investment ConferenceAMEX:OSTXOS Therapies Incorporated
29/08/202408:53Business WireOS Therapies Announces Last Patient Enrolled in OST-HER2 Osteosarcoma Phase 2b Clinical Trial Receives Last Treatment DoseAMEX:OSTXOS Therapies Incorporated
22/08/202409:00Business WireOS Therapies Appoints Borys Shor, PhD to ADC Advisory BoardAMEX:OSTXOS Therapies Incorporated
22/08/202407:00Business WireOS Therapies Clarifies CUSIP of Common StockAMEX:OSTXOS Therapies Incorporated
19/08/202409:30Business WireOS Therapies Accepted Into Johnson & Johnson Innovation - JLABSAMEX:OSTXOS Therapies Incorporated
02/08/202409:55Business WireOS Therapies Forms Osteosarcoma Patient Advocacy Advisory BoardAMEX:OSTXOS Therapies Incorporated
01/08/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:OSTXOS Therapies Incorporated
31/07/202419:21Business WireOS Therapies Announces Pricing of its Initial Public Offering on NYSE American - Company to Trade under Symbol “OSTX”AMEX:OSTXOS Therapies Incorporated
30/07/202415:41Edgar (US Regulatory)Form CERT - Certification by an exchange approving securities for listingAMEX:OSTXOS Therapies Incorporated
30/07/202415:29Edgar (US Regulatory)Form 8-A12B - Registration of securities [Section 12(b)]AMEX:OSTXOS Therapies Incorporated
24/07/202411:48Business WireOS Therapies Announces Positive Safety Data from Phase 1 Clinical Trial of OST-HER2 in HER2-Expressing Breast Cancer and in Preclinical Efficacy in Models of Breast CancerAMEX:OSTXOS Therapies Incorporated
03/06/202413:44Business WireOS Therapies Announces Positive Clinical Update from Ongoing Phase 2b Clinical Trial in Resected, Recurrent OsteosarcomaAMEX:OSTXOS Therapies Incorporated
 Apresentando as notícias mais relevantes sobre:AMEX:OSTX

Seu Histórico Recente

LSE
57GD
07dec2041c
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados